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ABSTRACT

CONVERSION AND REVERSION OF TUBERCULIN SKIN AND QUANTIFERON GOLDIN-TUBE TESTS AMONG PERSONS EXPERIENCING HOMELESSNESS DURING A
MULTI-SHELTER SCREENING EFFORT IN ATLANTA, GEORGIA (2008-2018)

by

RISHIKA MOHNISH PARIKH

Background: The aim of this study was to determine the proportion of persons experiencing
homelessness (PEH) who converted or reverted a tuberculin skin test (TST) or QuantiFERON
Gold-in-tube test (QFT) and examine the risk factors associated with prevalence of latent
tuberculosis infection.
Methods: We performed a retrospective cohort study of all PEH screened for latent tuberculosis
infection (LTBI) by TST or QFT from 2008-2018 in Fulton County, Georgia.
Results: Out of 16,444 PEH in the study cohort who were screened by TST or QFT, 1603 (9.7%,
95% Confidence Interval [CI] 9.2 – 10.1%) had a positive TB screening. Factors associated with
positive results were older age, being male, being Asian, HIV co-infection and history of
incarceration. Of those initially negative with a second test (n=3491), 8.5% became positive
during a total follow-up period of 102521 person-months, corresponding to an incidence rate of
2.9 cases per 1000 person-months. The rate of conversion was higher among male, older adults
and PEH with HIV. Of those initially positive with a second test (n=241), 36.5% reverted to
negative during a total follow-up period of 6655 person-months, corresponding to reversion rate
of 13.2 cases per 1000 person-months. The rate of reversion was highest among older adults.
Discussion: We found higher rates of QFT/TST conversion and reversion. Targeted QFT/TST
screening and LTBI treatment among PEH should be an active strategy to reduce TB morbidity.
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CHAPTER I
INTRODUCTION
1.1

Background
Tuberculosis (TB) disease is an infectious disease caused by the bacillus
Mycobacterium tuberculosis that typically affects the lungs. The infection causes a binary
condition that is either active TB disease or latent infection. One third of the global
population is estimated to be latently infected by Mycobacterium tuberculosis (Houben &
Dodd, 2016). Most of the infected people do not show any signs or symptoms of TB
disease and are not infectious. While this fragment of the population may not be
infectious, but they are at a risk of developing active TB disease and becoming infectious.
However, the progression of latent tuberculosis infection (LTBI) to active TB disease
depends on bacterial, host, and environmental factors (Getahun et al., 2015).The global
annual incidence is estimated to be 10 million, with an estimated 1.5 million deaths in
2018 (WHO, 2019). TB disease has been a leading cause of death worldwide and has
been a major public health concern for the last several centuries. Even though the global
incidence is projected to decline 1.6% each year (Furin, Cox, & Pai, 2019), the risk of TB
disease at least 10 folds higher in person experiencing homelessness (PEH) than the
general population (Bamrah et al., 2013).
The overall rate of homelessness in the United States at any given night in 2018
was 0.2% i.e. 17 persons per 10,000 people (The 2018 Annual Homeless Assessment
Report (AHAR) to Congress). They are exposed to numerous behavioral, social and
environmental risks that leads to increased communicable infections and are one of the
1
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reasons of an outbreak which become serious public health concern. The prevalence of
these communicable diseases depends greatly on the living conditions. PEH are at a
higher risk for latent and active TB (Nyamathi, Sands, Pattatucci-Aragón, Berg, & Leake,
2004). Substance abuse, incarceration, and human immunodeficiency virus (HIV) are
also the risk factors associated with TB (Bamrah et al., 2013). They are more likely to
spread TB and cause an outbreak due to compromised immunocompetency and delay in
seeking health care and treatment. PEH who sleep in shelters are majorly men, but they
also include women and families with children. The overcrowded conditions in the
homeless shelters expose them to airborne infections, especially TB is a primary health
concern for this population at risk (Badiaga, Raoult, & Brouqui, 2008). More than 5% of
TB cases reported to the National TB surveillance System have experienced
homelessness in the preceding year (Parriott et al., 2018).
TB was recognized as a disease that was associated with homelessness as early as
1914 (Bamrah et al., 2013). The spread of TB among PEH is related to person-to-person
transmission where TB is transmitted by droplet nuclei when a person with active TB
coughs or sneezes. Thus, this population are at a higher risk of progressing to active TB.
There is a necessity for interventions to control the spread of TB among such high risk
population by early detection of cases and outbreaks in shelters, screening of those
patients who has had contact with an infectious person, and effective treatment of TB
patients (Badiaga et al., 2008).
Our study was conducted in Fulton County of Atlanta, Georgia, where an
outbreak investigation for Drug-Resistant Mycobacterium tuberculosis was conducted
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among the homeless people during the period from 2008-2015. The majority of outbreak
associated patients had stayed overnight or volunteered at a homeless facility (Powell et
al., 2017).
1.2

Gap and Purpose of Study
Previous studies about LTBI in the homeless population or high-risk populations
have focused on the risk factors of LTBI and the performance of the screening test for TB
disease (Bagheri Amiri, Saifi, Gouya, Rohani, & Mostafavi, 2015; Getahun et al., 2015;
Laurenti et al., 2012). To our knowledge very few studies have examined the conversion
or reversion of a TB screening tests in the context of an active TB outbreak among PEH
in the United States (Doshi et al., 2012; Sivapalasingam et al., 2009). Given that 13
million people in the US have LTBI (CDC, 2019), it is important to describe the risk
factors of LTBI among PEH. Our study focused on determining rates of conversion and
reversion of TST and QFT screening tests.
The specific objectives of this study were to:
1. To examine risk factors associated with prevalence of positive QFT or TST at the time
of initial screening.
2. To determine the proportion of persons experiencing homelessness who converted a
tuberculin skin test (TST) or QuantiFERON Gold-in-tube test (QFT) from negative to
positive.
3. To determine the proportion of persons experiencing homelessness who reverted a
tuberculin skin test (TST) or QuantiFERON Gold-in-tube test (QFT) from positive to
negative.

CHAPTER II
REVIEW OF LITERATURE
2.1

Tuberculosis
Primary tuberculosis occurs when the body is unable to defend against

Mycobacterium tuberculosis bacterium (MTB) infection. The lung is the most involved
organ, although the gastrointestinal system, the musculoskeletal system, the lymph
reticular system, skin, liver, and the reproductive system may also become infected. The
organism is spread primarily as an airborne aerosol from an individual infected with
tuberculosis. The deposition of the organism can lead to primary disease (i.e. immediate
onset of active disease), latent infection or reactivation of the disease. The body’s ability
to effectively restrict the infective bacteria id dependent on the individuals’ immune
system, genetics and whether the exposure is primary or secondary (Jilani, Avula,
Gondal, & Siddiqui, 2019).
LTBI is characterized by a state of persistent immune response to stimulation by
antigens without any clinical evidence of active tuberculosis (WHO, 2018). The lifetime
risk of reactivation TB for any person with documented LTBI is estimated to be 5-15%,
with the majority developing the TB disease within the first 5 years after initial infection
(Bamrah et al., 2013).
Amongst the many diagnostic tools used for screening tuberculosis infect,
Tuberculin skin test (The Mantoux test) and interferon-gamma release assay assist in
diagnosis (Jilani et al., 2019). In addition to these screening methods, proper diagnosis of
LTBI requires that the presence of active TB infection be excluded. A chest radiography
4
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or in certain circumstances, sputum examinations should be performed to eliminate the
possibility of active TB infection should be performed to eliminate the possibility of
active TB infection (CDC, 2019; Kim & Kim, 2018). The treatment regimens for LTBI
can be given under directly observed therapy (DOT) or self-administered therapy (SAT).
The treatment regimens are decided based on severity and patient attributes. They include
a 12-dose regimen of Izoniazid (INH) and Rifapentine (RPT), a 4- month regimen of
Rifampin (RIF), a 9/6- month regimen of INH or 4-month regimen of INH and RIF
(CDC, 2019; WHO, 2018)
2.2 Risk factors for LTBI
While we make efforts to control and eliminate TB globally, the foremost
challenge there exists is the large often overlapping socially and medically vulnerable
population among whom the LTBI subgroups have a significantly higher risk of
progression into active TB disease due to a compromised immune or nutritional status
(Nandini Sharma, Saurav Basu, & Kamal K. Chopra, 2019).
The current established risk factor for LTBI is close contacts with active
tuberculosis patients. It poses as a higher risk for both active and latent TB infections. A
close contact is defined as living in the same household or frequent contact with a source
case with sputum smear positive. Cases who are sputum smear negative but culturepositive are also infectious, but to a much lesser extent ("Guidance for National
Tuberculosis Programmes on the management of tuberculosis in children. Chapter 1:
introduction and diagnosis of tuberculosis in children," 2006). A close contacts of culture
positive TB patients who visited Gyeongsang National University Hospital in South
Korea, were prospectively enrolled to identify the predominant risk factors of contracting

6

LTBI when in close contact with active TB patients. The enrolled subjects were
household or work contacts of patients with active TB. Out of the 308 subjects, 38% were
tuberculin skin test (TST) positive and 28.6% were QuantiFERON-TB Gold test (QFT)
positive. The TST positivity was significantly associated with the male gender (p=0.049),
history of TB (p=0.008), and household contact (p=0.01). The prevalence of LTBI among
close contacts of active TB was high, and prior TB history and household contact were
risk factors for LTBI (S. J. Lee et al., 2014). Another study conducted in a tertiary
hospital in South Korea, observed a prevalence of LTBI to be 15.8% among the 499
health care workers (HCWs). Additionally, the prevalence of exposure to pretreatment
TB patients was higher among HCWs in TB-related departments, than among HCWs
working in a Tb-unrelated department (Park, 2018). These findings indicate that close
contacts with active TB patients has a higher chance of acquiring LTBI.
Demographics that were associated with increased risk of LTBI include
increasing age, lower educational and socio-economic status, and alcohol use (Yap et al.,
2018). Risk factors for LTBI were significantly associated with living with a relative with
TB, history of incarceration, diabetes (Martínez-Aguilar et al., 2015), and Smoking
(Amere, Nayak, Salindri, Narayan, & Magee, 2018), There is evidence of increased risk
of LTBI and active TB among people living with HIV, substance abuse, and smokers
(Getahun et al., 2015). Chronic exposure to silica, undernutrition with low BMI in adults
and malnutrition in under-5 children were reported to increase the risk of LTBI (N.
Sharma, S. Basu, & K. K. Chopra, 2019). People with Hepatitis C virus (HCV) infection
were also found to be at a higher risk for LTBI and active TB disease (Armenta et al.,
2017).
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A few studies have been conducted in the United States and other countries,
investigating diabetes as a risk factor for LTBI. A cross-sectional analysis was performed
using National Health and Nutrition Examination Survey data for 2011-2012 determining
the association between prediabetes and diabetes with LTBI. Out of the 9756 participants,
793 eligible participants had diabetes, 513 had LTBI and 127 had both diabetes and
LTBI. Prevalence of diabetes among adults in the United States population was 11.4%
and the prevalence of prediabetes was 22.1%. Prevalence of LTBI was seen to be
significantly higher among adults with diabetes (11.6%) compared to those without
diabetes (4.6%). LTBI prevalence was also higher among those participants with
prediabetes (7.0%) (Barron, Shaw, Bullard, Ali, & Magee, 2018). Another study was
conducted to estimate the population-level impact of diabetes on the incidence of
pulmonary tuberculosis in India. The country of India was chosen for the study for its
large population size and availability of the required data. The study estimated that
diabetes accounted for 14.8% of incident pulmonary tuberculosis in India in 2000. While,
the proportion of incident smear-positive tuberculosis due to diabetes was estimated to be
20.2%. The study also predicted that the prevalence of pulmonary tuberculosis in patients
with diabetes in India is 18.4 %, and that in the smear-positive group diabetes prevalence
is 23.5% (Stevenson et al., 2007).
A study conducted in San Diego County, CA investigated the LTBI prevalence by
birth regions and clinical risk factors. It identified the demographic and clinical risk
factors associated with LTBI treatment among newly arrived refugees from January 1,
2010, through October 1, 2012. The prevalence of LTBI was the highest among the
refugees from Saharan Africa (43%) and was associated with current smoking status and
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having other clinical comorbidity which in turn increases the risk of active TB. Even
though the prevalence of LTBI was high amongst this specific group of refugees, they
were found to be less likely to initiate treatment than other refugees from the Middle
East. The study also found that refugees who had a post-secondary education were more
likely to initiate a treatment for LTBI (Bennett, Brodine, Waalen, Moser, & Rodwell,
2014).
World Health Organization in 2018 reported tuberculosis as the most important
co-infection in HIV epidemic, with an estimated 0.8 million TB cases attributable to HIV.
HIV is not only found to increase the risk of reactivating LTBI, but also increases the risk
of rapid TB progression soon after infection of reactivation of LTBI. A review study for 6
WHO regions and 22 high burden countries was conducted by obtaining the data from the
Joint United Nations Program on HIV/AIDS (UNAIDS) to understand the increasing
global burden of TB liked to HIV. Tuberculosis incidence rates were the highest in the
WHO African Region (265/100,000 population, in addition to the annual rate of increase
in the number of cases (6%). Out of all the new TB cases, 9% (7%-12%) of the cases in
adults were attributable to HIV infection. The study also estimated 1.8 million deaths
from TB, out of which 12% (226,000) were attributable to HIV. The prevalence of LTBIHIV co-infection was estimated to be 0.36% (11 million people). The high prevalence of
HIV and TB co-infection presents a massive challenge to global TB control (Corbett et
al., 2003). Another study conducted in southern Brazil, aimed to identify the prevalence
of LTBI in persons living with HIV/AIDS (PLWHA) and progression to active
tuberculosis among the identified cases. Among the 690 individuals in the sample with
HIV, 9.6 % of the sample were diagnosed with LTBI presenting a prevalence of 7.5 cases
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observed for every 100 patients. 47 (6.7%) of the identified LTBI cases progressed to
active tuberculosis among PLWHA (Santos et al., 2017). These findings for the research
reinforce the risk of LTBI among high risk group of people living with HIV/AIDS.
2.3 Homelessness and risk of LTBI
Homelessness is recognized to be an economic and social issue that is relevant to
the society. A retrospective study was conducted in Houston, Texas where they aimed to
calculate the rate of TB disease among the homeless population. The study cohort
included 4312 TB cases from October 1995 to September 2004. The average rate of TB
was found to be 9.5 among housed persons and 411 among homeless persons per
100,000. The univariate analysis revealed that the homeless were more likely than housed
participants to belong to the Beijing family. The study found that being White, male,
unmarried or unemployed; reporting a military service; engaging in transactional sex;
reported history of incarceration or injection or non-injection drug use; and belonging to
the genotyping clusters p1, p3, p16, p22, or p33 all remained positively associated with
homelessness (OR>1.4) (Feske, Teeter, Musser, & Graviss, 2013).
Another cross-sectional study was conducted in Seoul metropolitan city, South
Korea that aimed to explore the prevalence rate of LTBI and active TB among homeless,
and to compare the TB burden among homeless people with that of the control group.
Out of the 313 participants, 309 (98.7%) were male, 17 % had a history of previous TB,
bacille Calmette-Guerin (BCG) scars were present among 68.8 % participants. 5.8 %
participants had active pulmonary TB that were identified by chest x-ray (CXR), and the
prevalence rate of active TB among homeless was much higher than that in general
population. 206 out of 258 (79.8%) were TST positive and 224 out of 295 (75.9%) were
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GFT positive, therefore, positive rates of QFT and TST screening for LTBI were much
higher for the homeless participants compared with the controls. The higher prevalence
rate of active TB and LTBI among the homeless in South Korea was 25 times and 6 times
higher as compared with the US and Japan respectively (C.-H. Lee et al., 2013).
2.4 Persons experiencing homelessness and other comorbidities
Previous research has been done on PEH that have demonstrated their elevated
risk of asymptomatic TB infection, active TB and multi-drug resistant TB. Substance
abuse, incarceration, and HIV have been established as conditions that more frequently
affect PEH and are risk factors for TB infection (Bamrah et al., 2013). There is
multiplicity of factors among the homeless population that have contributed to the
resurgence of TB, such as increasing poverty, budget-constraints on local health, illicit
drug use, immigration from high prevalent countries, and non-compliance among TB
patients. Bamrah et al., examined the demographic information and TB outcomes among
the homeless persons with TB during 1994-2010. The prevalence of reported HIV
coinfection was found to be higher among both US born and foreign-born homeless with
TB than in the non-homeless (22% vs 9% and 15% vs 5%, respectively). Additionally,
substance abuse was strongly associated with homeless than the non-homeless. The odds
of substance abuse were 8.3 (95 %CI 8.0-8.7) among US-born homeless TB patients and
12.3 (95% CI 11.5-13.2) among foreign-born homeless TB patients (Bamrah et al., 2013).
Another study conducted in Argentina to determine the main comorbidities,
associated conditions, clinical and microbiological characteristics of adult TB patients.
With a median age of 37 years, males were associated with extrapulmonary TB,
hospitalization, smoking, drug addiction and alcoholism. TB and AIDS (22.6%) was
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related to drug use, admission into hospital, extrapulmonary TB, non-addiction to
tobacco, non-pathological radiology, and negative sputum smear microscopy. The study
also estimated that patients who were less than 40 years of age had a higher rate of drug
addiction and low weight, while those who were 40 years of age and older had a higher
proportion of diabetes, alcoholism, and chronic pulmonary disease (COPD) (Echazarreta
et al., 2018).
These aforementioned risks established by previous research, not only help to
recognize the characteristics and comorbidities, but also help to influence the
development of social and community-based strategies.
2.5 Screening and diagnosis of LTBI among persons experiencing homelessness
The sequence of steps diagnosing TB are identify the population to be tested, test
with-γ release assays (IGRAs) or TST (including evaluation to exclude active
tuberculosis if test is positive), initiate treatment in the people to test positive for LTBI,
and complete treatment. People who fail to complete any of these diagnostic steps results
in transmission of disease that has multiplicative effects (LoBue & Mermin, 2017).
A study was conducted in Denver, Colorado that described the implementation of
a mandatory screening program consisting of symptom screening and TST testing in
homeless shelters and evaluate its effect on TB incidence and transmission. The
screening test were provided at some overnight shelters, at a day shelter, and a clinic for
the homeless. The data for this study was collected between January 1995 and December
1998. The estimated number of homeless increased from 3,330 in 1995 to 5,792 in 1998,
largely attributable to the growing metropolitan area. The number of homeless
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individuals who were screened for LTBI increased from 893 in 1995 to 3,897 in 1998.
The screening ration increased from 26.7 to 67.3 per 100 persons during that period.
They also found that the proportion of positive TST decreased during the study period.
Although the number of homeless people increased, the incidence of active TB decreased
from 510 to 121 per 100,000 persons during the study period. The screening program had
successful outcomes in early identification of LTBI, however, the treatment of LTBI had
low acceptance and completion rates (Kong et al., 2002).
An interesting qualitative cross-sectional study was conducted as a result of the
large TB outbreak involving homeless shelters in Atlanta, Georgia. It involved in dept
interviews with 10 PEH with active TB disease. The goal was to inform the ongoing TB
control efforts and contribute hypothesis-generating data for further research on TB
elimination in this setting. The perspective of LTBI and active TB is underrepresented
among PEH, thus, the study also aimed to explore how these participants who belong to a
high-risk population, experience illness and shelter-based interventions. Out of the 10
PEH, 50% previously completed TB treatment, 50% were infected with HIV, 70% selfreported substance abuse, and all had history of substance abuse. A few participant
testaments: Everybody keeps it (health status) quiet. They don't want to (disclose
symptoms or seek help)—they feel like they'll be discriminated against and stuff like that.
(Participant 7); I would rather be hung from a tree than to sleep in there … again.
(Participant 6); I don't want to go back to the shelter. It's worse than jail without the
bars. (Participant 1). The stressful and unpleasing shelter environment appeared to
reduce the impact of public health interventions. The health was de-prioritized and
delayed care was observed among these shelter homes. Shelter related stress was
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observed to be an important implication for the prevention and control of TB outbreak
(Connors et al., 2017).
2.6 Summary of literature review
•

The association between person experiencing homelessness and latent tuberculosis
infection have been established through previous studies.

•

Majority of the studies with regards to the homeless population have examined the risk
factors associated with latent tuberculosis infection, however the adherence to treatment
and tuberculosis management for this high-risk population is under studied.

•

Very few studies have been found examining the test conversion and a reversion among
persons experiencing homelessness.

CHAPTER III
MANUSCRIPT
Introduction
Although great improvements have been made in reducing the rate of tuberculosis (TB)
outbreaks, active TB remains a public health concern in the US, especially among populations at
high-risk [1, 2]. One population at high-risk of TB in the US includes persons experiencing
homeless (PEH). Homelessness has been linked to major outbreaks of TB in the US in the past
[1, 3]. In 2018 an estimated 553,000 people in the US were experiencing homelessness including
individuals who slept in homeless shelters, on the streets or in other locations [3, 4]. For PEH,
the risk of acquiring TB infection is 10 times higher than the risk among the general population
[5]. In addition, PEH experience who acquire TB disease have worse disease outcomes and are
more likely to be hospitalized than the general population [6] [7].
The US Centers for Disease Control and Prevention (CDC) guidelines indicate targeted
screening for LTBI among at-risk populations including PEH. Expanded LTBI screening efforts
among PEH in the US led to a decrease in TB incidence rates from 1,502 cases per 100,000 in
1992 to 171 cases per 100,000 in 2004. [9]. Nonetheless PEH present many challenges for TB
control regarding LTBI screening and treatment [5]. Social stigma, isolation and secrecy
associated with diagnosis of LTBI pose additional barriers to accessing health care [12].
Facilities serving PEH have increased risk of TB transmission due to congregate nature
of the housing in the shelters. Concurrent risk factors for LTBI among PEH exist include comorbidities, mental illness, inadequate food supply, concurrent substance use, and increased
history of incarceration [7, 13-15].

14

15

One of the largest TB outbreaks among homeless persons in recent history occurred in
Atlanta, Georgia. It started in March 2008 at one homeless facility and spread to other shelters
within the metro Atlanta areas. [16]. In Fulton County, one of the jurisdictions that comprise the
metropolitan Atlanta, the outbreak resulted in a 3-fold increase in the number of active TB cases
among PEH in 2014 [17, 18]. The Fulton County health department in response to the outbreak
began sporadic screening of individuals who use transitional housing facilities within the metro
Atlanta area. However, a resurgence of the outbreak in 2014 led to the implementation of a
targeted screening program at all Atlanta shelters in mid-2015, requiring mandatory screening of
all individuals accessing all homeless housing facilities located in the metro-Atlanta area within
seven days of initial contact with the shelter. This effort was aimed at identifying new, untreated
LTBI, reinforcing environmental control measures at the shelters and linking individuals with
untreated LTBI to treatment. During the initial year of implementing the screening program,
participants were screened using Tuberculin Skin Test (TST) onsite at the health department, as
well as off site at the homeless shelters. QuantiFERON-TB Gold-in-Tube (QFT; QIAGEN Inc,
Germantown, MD) screening test was introduced in subsequent years and was used as the
primarily method of screening offsite at the homeless shelters [18]. Several studies have
described various aspects of this Atlanta TB outbreak [18-20]. However, there has not been any
study evaluating TB screening conversions and reversions among the individuals screened
during this major TB screening effort in Atlanta. The primary objective of this study was to
examine the proportion of PEH who screened positive for TST/QFT after an initial negative
screening during the targeted program in Fulton County, Georgia. We also describe the
proportion of PEH who reverted to a negative after a positive TST/QFT screening test. We also
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aimed to describe the socio-demographic factors associated with the prevalence of LTBI among
PEH.
Methods
Setting and study design
We conducted a retrospective cohort study of PEH screened for LTBI by Fulton County Board
of Health (FCBOH) between 2008 and 2018. During the initial and quiescent phases of the
outbreak (2008 – 2014), the Fulton County health department conducted sporadic TB screening
exercises at affected homeless facilities, screening individuals who agreed to be screened [19]. A
resurgence of the outbreak in 2014 led to the establishment of a collaboration between the health
department and Mercy Care, a local federally qualified health center, to create the Metro Atlanta
TB task force which encompassed representatives from public health centers, homeless shelters,
and other community service providers within the metro Atlanta area [20]. In addition, new
screening guidelines were also enacted in 2015, making TB screening mandatory for all users of
homeless facilities. All new and intending shelter residents were required to get screened for TB
within seven days of shelter entry and every six months thereafter [18, 20]. PEH were screened
by TST or QFT at both the shelter locations and at TB clinic at the health department. The
screening tests were analyzed and interpreted according to the Centers of Disease Control and
Prevention (CDC) guidelines [18, 21, 22].
Study Population
Eligible participants included 16,444 individuals who were attained by excluding participants
less than 18 years of age (N=301), screening with TST or QFT test results that were missing
(N=135), indeterminate and not read test results (N=2341) (Figure 1). The study population
initially included a total of 19,221 unique PEH who were screened between 2008 and 2018.
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Unique identifiers were created to determine individuals who had repeat screenings during the
10-year period. To determine prevalence of LTBI among the PEH screened during the entire
duration, we used the first screening on record as the entry LTBI status. [18].
Study Outcomes and Variables
There were two primary outcomes in this study – 1) time to conversion (TTC) from a
negative to a positive TB screening test and 2) time to reversion (TTR) from a positive to a
negative TB screening test. Among PEH who had negative TB screening results at the entry
screening, TTC was defined as the duration between the date of the entry screening (i.e. date of
initial TB screening) and the date of first positive TB screening test (if conversion was
observed). Among PEH who had a positive TB screening result at entry screening, TTR was
defined as the duration between the date of entry screening and the first negative TB screening
(if reversion was observed). Participants at entry screening or follow-up screening were
screened either by TST or QFT. They were necessarily given identical tests during the entry and
follow-up screenings. Thus, conversion of TB screening test was defined by TST or QFT
positivity irrespective of the type of test administered at entry screening.
Other variables included in the analysis are demographic characteristics (Race/ethnicity,
gender, and age), year of entry screening, social history (incarceration), behavioral history
(substance use defined by alcohol, and injection or non-injection drug use) and personal medical
history (HIV and diabetes). Social and personal medical histories were all self-reported. The year
of entry screening was characterized by before (pre-2015) and after (post-2015) the new
screening guidelines were enacted. The data for history of incarceration in the past 2 years was
added to the questionnaire in 2016, there is no available data prior to 2016. These independent
variables in the analysis were included based on previous literature review.

18

Statistical Analysis
Unadjusted logistic regression analyses were conducted to explore socio-demographic
characteristics associated with LTBI prevalence at entry screening. Incidence rates and incident
rate ratios were calculated to examine conversion and reversion among PEH who were negative
and positive at entry screening. Kaplan Meier curves were used to examine time to conversion
and reversion. Patients were censored if they were lost to follow up for rescreening for LTBI. A
two-sided p-value <0.05 was considered significant in all analyses. All statistical analyses were
performed using SAS version 9.4 and Open Source Epidemiologic Statistics (OpenEpi) version
3.01.
Ethical Approval
This study has been reviewed and approved by Institutional Review Board at the Georgia
Department of Public Health and Georgia State University.
Results
Between 2008 and 2018, there were 16,444 homeless individuals with viable TB
screening results at initial screening (Figure 1). The median age was 45 years (IQR=20), 78.3%
were male, and 85.5% were non-Hispanic Blacks/African Americans. At entry screening, 1603
(9.7%, 95% Confidence Interval [CI] 9.2 – 10.1%) PEH among the 16,444 PEH screened had a
positive TB screening.
Odds of having LTBI at entry was higher among PEH who were over 65 years old
(Crude Odds Ratio (cOR) 9.1; 95% CI 5.9-14.1; p<0.001) and those aged between 45 and 64
years old (cOR 5.9; 95% CI 4.1-8.4; p<0.001) compared to younger PEH (Table 1). The odds of
being positive at baseline was significantly higher among male PEH (cOR 2.1; 95% CI 1.8-2.5,
p<0.001) compared to female PEH. PEH who were Asians had higher odds of being positive at
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baseline as compared to other races (cOR 3.7, 95% CI 1.9-7.3; p<0.001). PEH who were
screened pre-2015 had higher odds of being positive at baseline TB screening compared to those
screened post-2015 (cOR 12.3; 95% CI 10.7-14.2, p<0.0001). Although, large portion of HIV
data was missing for this cohort (68.8%), PEH who were HIV positive had an increased odd of
LTBI at baseline (OR 1.5; 95% CI 1.3 – 2.4, p<0.05). PEH who had a history of recent
incarceration were also observed to have higher odds of being positive at baseline compared to
those who did not report incarceration history (cOR 1.3; 95% CI 0.7-2.2)
Among the 14,841 unique persons with a negative TB screening test at baseline, 3491
(23.5%) participants had at least one subsequent TB screening within the study period and 298
(8.5%) of those became positive during the follow-up period (Table2). Overall rate of incident
QFT or TST conversion was 2.9 cases per 1,000 person-months (95% CI 2.6-3.2).
The rate of QFT/TST conversion was higher among male PEH (Incident Rate Ratio
[IRR] 2.7; 95% CI 1.7 – 4.4; p<0.001) compared to the female PEH. Rate of conversion of TST or
QFT was significantly higher among older PEH, 65+ years old (IRR 3.8; 95% CI 1.5 – 9.4,

p<0.01) compared to younger age groups. Additionally, PEH who had diabetes were also
observed to have a higher rate of conversion (IRR 1.2; 95% 0.7-2.0) compared to those who did
not have diabetes. Participants who had 1 to 3 follow up screenings in addition to the entry
screening were observed to have a conversion rate of 3.3 cases per 1000 person months. The rate
of conversion was higher among PEH screened post-2015 (IRR 1.4, 95% CI 1.1-1.8; p<0.01)
compared to those who were screened pre-2015. Figure 2 describes the factors associated with
the conversion IRR.
Among those 1,603 participants who had a positive TB screening result at entry
screening, 241(15%) participants had at least one subsequent TB screening. Of those 241
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persons, 88 (37%) PEH reverted from a positive to a negative result during the follow-up period
(Table 3). Overall rate of reversion from positive to negative was 13.2 per 1000 person months
(95% CI 10.7-16.2). Reversion rate was observed to be higher in females and male PEH (17.9
per 1000 person months). The PEH belonging to the older age group (65+ years) had a higher
rate of reversion (30.8 per 1000 person months; 95% CI 2.3-907.6) as compared to the other
young age groups. Reversion rate was higher among those screened using TST at baseline (90.9
per 1000 person months) than among those screened using QFT at baseline (35.2 per 1000
person months). Reversion rate was also observed to be higher in Non-Hispanic Whites (30.0 per
1000 person months) as compared to Non-Hispanic Blacks (12.4 per 1000 person months) and
Asians (17.5 per 1000 person months). Participants who had 7 to 15 follow up screenings in
addition to the entry screening were observed to have a reversion rate of 15.4 cases per 1000
person months.
Table 4 describes the demographic characteristics for PEH with and without follow-up
screenings. In this study, 12,712 PEH were lost to follow-up after the first screening. This may
have occurred due to PEH not returning for TST reading, or continued instability in housing may
have led to frequent patient relocation. Out of the individuals who were screened at baseline
without any follow up screenings, 76% were male, and 84 % were Non-Hispanic Blacks. Even
though, we observed significant associations between gender, race, age-groups and LTBI, it
would have been beneficial to manage transmission of TB if we had more persons with followup screenings.
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Discussion
Overall, we found that being male, older and Asian were independent risk factors for
prevalence of LTBI. Our findings also suggested that of the 16,444 screened participants, 70%
were screened post-2015 i.e. after mandatory screening at shelters was implemented. Overall
prevalence of LTBI was also found to be higher among PEH who HIV were positive. The high
incident rates among people who had follow-up screening were associated with being male, NonHispanic Blacks, old (65+) and having diabetes (Figure 2). While, the high reversion rates were
associated with being female, Non-Hispanic Whites, old (65+), and being screened by TST at
baseline screening.
Homelessness is recognized to be an economic and social issue that presents a great
challenge to achieve the national goal of TB elimination. They represent a plausible source of
increased transmission of TB across socially diverse populations [7, 23]. Overall, we found a
TST/QFT positivity prevalence of 9.7% among PEH in Atlanta, GA. Consistent with previous
studies [24-26], diagnosis of LTBI among PEH was significantly associated with male gender,
older age and Non-Hispanic Blacks. The prevalence of LTBI may be higher in men as compared
to women because of behavioral factors associated with mobility and social crowding [24, 25].
However, another possible explanation for lower prevalence in women is associated with
diagnostic delays and subsequent delays in seeking health services [27]. This also supports our
finding, that rate of incident TB infection was higher among male PEH as compared to female
PEH. There is evidence that when women are enrolled in health care, they are more likely than
men to adhere to treatment resulting in better treatment outcomes [28]. Additionally, we
observed that women had a higher rate of reverting from positive to negative TST or QFT.
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The global population is ageing quickly and represents a large reservoir of TB infection.
Few studies have reported that TB incidence is higher among older age groups [29, 30].
Consistent with this study’s finding, a longitudinal study conducted in China reported higher
total incidence and mortality among older (aged 65 years and older) people (193.0 cases per
100,000 people and 18.7 deaths per 100,000 people, respectively) [31]. A cross-sectional study
conducted of Zambian residents reported TB prevalence of 0.7% among those who aged ≥55
compared to those who belonged to the 15-54 age group (0.3%) [32].
Consistent with our findings that Asians, Hispanics and Non-Hispanic Blacks were more
likely to be diagnosed with LTBI at entry screening, a cross-sectional study conducted on 20112012 NHANES data also found Asians had the highest LTBI prevalence (21.3%) followed by
Hispanics (11.7%) and Non-Hispanic Blacks (6.3%) [33]. A cross-sectional study of TB
surveillance data conducted Michigan also found that among the clustered TB cases, the average
incidence rate among Blacks was 25 times and among Asians was 19 times higher than White,
after controlling for nativity, gender, and age [26], this was not supported by our finding for
incidence rate ratio stratified by race/ethnicity. However, our findings were consistent with a
prospective cohort analysis conducted in New York City, where they observed that Asian
ethnicity were at increased risk for conversion [34].
TST is currently the widely used method for identifying tuberculosis infection in person
who do not have TB disease [21] followed by QFT [22]. QFT is preferred in detection of LTBI
as compared with TST, not only because it has greater specificity but also a follow-up visit is not
required for the reading of the test [35]. There is also evidence that implies adherence with
follow-up visit for TST reading is poor amongst PEH [3, 18]. Although, this was not entirely
supported by our finding where PEH who had at least one subsequent follow-up visit were
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initially screened by TST (75%), which indicated increased adherence to follow-up with TST as
compared to QFT (Table 4). In addition to this finding, we also found that the reversion rate was
higher among those who were screened using TST at baseline than among those who were
screened using QFT.
PEH who have been incarcerated or who use drugs are at a high risk of HIV. HIV is a
known greatest risk factor for TB disease and greatest risk factor for progression of LTBI to
active TB disease [23, 36, 37]. Although, incarceration history was not captured until 2016, our
findings were yet consistent with previous studies that PEH with history of incarceration or HIV
were more likely to be diagnosed with LTBI. Prevalence of diabetes is increasing globally and
presents a three-fold risk of TB among those with diabetes [38]. We did not observe any
significant association between diabetes, substance use and TB prevalence for PEH who were
tested at entry screening, almost certainly because 77% of data for diabetes and 79 % data for
substance use was missing. Therefore, we may be underestimating the risk for TB transmission
among PEH with diabetes or substance use. This may be a result of recall bias where individuals
may less accurately remember history of diabetes or not report substance use (alcohol use,
injection or non-injection drug use, and smoking pattern).
Limitations
This study was also subject to several limitations. The study had many individuals who
did not return for TST reading, but we assumed the LTBI prevalence in those lost to follow-up to
be the same as those who remained in the study [18]. In addition, the TST and QFT screening
interventions were implemented over different time period and different settings ( clinic or field),
so it is possible that the consistency in administration of same TB screening test (i.e. > = 2 TST
or QFT tests) may have accounted for some difference in concordance among these tests.
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Although interferon-γ release assays (IGRAs) (such as QFT) and TST may be used in the
diagnosis of LTBI, they do not give equivalent information and often have discordant results [33,
34, 39-46]. In high-income, low TB incidence countries the QFT is especially suited due to better
specificity and in older persons due to its superior sensitivity [47, 48]. Additionally, foreign birth
[46], belonging to African ancestry [41], variable immune response like medications, stress and
previous infection [42] are associated with discordance. IGRA is a dynamic test that tend to
fluctuate according the variable status of TB infection [49] while its limitation is its inability to
differentiate between recent or remote infection [50]. Therefore, it seems that knowledge of
exposure is critical in assessing TB infection. It is also important to be note that the individuals
who consented for LTBI screening were given an incentive, which may have led them to falsely
report their homelessness and may not have any intensions to follow-up causing selection bias.
The Fulton County health department did not collect data for history of incarceration from 20082015, this may have therefore underestimated the transmission of TB amongst this at-risk
population. Most of the PEH who were lost to follow-up could not be reached and its reasons are
not completely evaluated. Non-reporting/response bias of HIV, substance use and diabetes status
led to increased proportion of missing data which may be because of unique stigma attached to
HIV, fear of reprisal connected to substance use, or unawareness of diabetes status. Thus, in this
population-based study misclassification bias may be enforced. There would be a biased estimate
of proportion of population with above exposure resulting into LTBI. Finally, some of these
predictors in the analysis were self-reported and may have resulted in misclassification.
However, previous studies have reported high validity of self-reported health risk behaviors [51],
therefore we believe the misclassification may not have led to substantial bias in our reported
measure of association.
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Conclusion
In summary, among the PEH in Atlanta, we found a high conversion rate of 2.9 per 1000
person-months. Being male, 65 years and older, HIV co-infected and having a history of
incarceration within the prior two years were independent risk factors for conversion.
Additionally, we found a high reversion rate of 13.2 per 1000 months. This implies that the
screening program more likely resulted in early diagnosis and treatment of LTBI [52]. PEH are
at increased risk for TB infection and therefore, to prevent future TB outbreaks, health
departments should continue routine screening and re-screening among this high-risk populations
of persons experiencing homelessness [36].
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TABLE - RESULT
Table 1. Distribution of demographic characteristics and tuberculosis (TB) screening positivity at
initial encounters among persons experiencing homelessness in Atlanta, Georgia, 2008 – 2018

Socio-demographic
Characteristics

Gender
Female
Male
Transgender
Race
Non-Hispanic
Black
Non-Hispanic
White
Asian
Hispanic
Other
Missing2
Age group
18-24
25-44
45-65
65+
HIV4
Negative
Positive
Missing3
Screening Type
TST
QFT
Missing2,3
Screening Location
Clinic
Field
Year of entry
screening
Pre – 2015
Post – 2015
Diabetes5
No
Yes

PEH who were
diagnosed with
LTBI during
entry screening
N (%)1

PEH who were not
diagnosed with
LTBI during entry
screening
N (%)1

N = 1603

N = 14841

N = 16444

194 (5.5)
1406 (10.9)
3 (8.3)

3345 (94.5)
11463 (89.1)
33 (91.7)

3539 (100.0)
12869 (100.0)
36 (100.0)

Ref
2.1 (1.8-2.5) ***
1.6 (0.5-5.2)

1458 (10.4)

12595 (89.6)

14053 (100.0)

1.9 (1.6-2.3) ***

119 (5.6)

1999 (94.4)

2118 (100.0)

Ref

11 (18.0)
7 (15.6)
5 (4.5)
3

50 (82.0)
38 (84.4)
106 (95.5)
53

61 (100.0)
45 (100.0)
111 (100.0)
56

3.7 (1.9-7.3) ***
3.1 (1.3-7.1) **
0.8 (0.3-2.0)

32 (2.7)
396 (5.64)
1104 (14.0)
71 (20.2)

1151 (97.3)
6623 (43.8)
6787 (86.0)
280 (79.8)

1183 (100.0)
7019 (100.0)
7891 (100.0)
351 (100.0)

Ref
2.2 (1.5-3.1) ***
5.9 (4.1-8.4) ***
9.1 (5.9-14.1) ***

497 (10.0)
26 (14.6)
1080 (9.5)

4460 (90.0)
152 (85.4)
10229 (90.5)

4957 (100.0)
178 (100.0)
11309 (100.0)

Ref
1.5 (1.0-2.4) *

924 (9.5)
548 (8.3)
131

8823 (90.5)
6018 (91.7)
0

9747 (100.0)
6566 (100.0)
131

Ref
0.9 (0.8-1.0) *

841 (10.)
762 (9.5)

7614 (90.0)
7227 (90.5)

8455 (100.0)
7989 (100.0)

Ref
0.9 (0.9-1.1)

549 (11.1)
1054 (9.2)

4410 (88.9)
10431 (90.8)

4959 (100.0)
11485 (100.0)

12.3 (10.7-14.2) ***
Ref

337 (10.0)
37 (9.6)

3027 (90.0)
350 (90.4)

3364 (100.0)
387 (100.0)

Ref
0.9 (0.7-1.3)

Total
N (%)1

Crude OR
(95% CI)

34
Missing3
Substance Abuse6
No
Yes
Missing3
Recent incarceration7
No
Yes
Missing3

1229 (9.7)

11464 (90.3)

12693 (100.0)

304 (9.6)
25 (9.9)

2868 (90.4)
227 (90.1)

Ref
1.0 (0.7-1.6)

1274

11746

3172 (100.00)
252 (100.00)
13020
(100.00)

66 (8.6)
18 (10.8)
749

697 (91.4)
148 (89.2)
7381

763 (100.0)
166 (100.0)
8130 (100.0)

Ref
1.3 (0.7-2.2)

Abbreviations: LTBI – Latent Tuberculosis Infection; PEH – Persons Experiencing Homelessness; TST
– Tuberculin Skin Test; QFT – QuantiFERON-Tuberculosis; HIV – Human Immunodeficiency Virus.
1
Table displays the row numbers followed by row percentage in parenthesis.
2
Missing data is not counted in calculating percentage since the missing value is relatively less.
3
Odds ratio is not calculated for missing data.
4
HIV was defined as any HIV screening test conducted and/or self-reported diagnosis.
5
Diabetes was defined as a self-reported diagnosis.
6
Any substance abuse was defined as self-reported excessive alcohol use or injection/non-injection drug
use.
7
Incarceration information was collected from patients only beginning of May 2016.
*p≤.05. **p≤.01. ***p≤ .001
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Table 2. Rate of conversions from negative to positive tuberculosis (TB) screening result during
subsequent TB screening encounters among persons experiencing homelessness who tested
negative at initial TB screening encounters in Atlanta, GA, US Georgia, 2008-2018

Socio-demographic
Characteristics

All PEH N=3491
Gender2
Female
Male
Race
Non-Hispanic Black
Non-Hispanic White
Asian
Hispanic
Other
Missing3
Age group
18-24
25-44
45-65
65+
HIV4
Negative
Positive
Missing3
Screening Type
TST
QFT
Screening Location
Clinic
Field
Year of entry
screening
Pre – 2015
Post – 2015
Diabetes5
No
Yes
Missing3

Remained
negative at
subsequent TB
screenings
N (%)1

Became
positive at
subsequent
TB
screenings
N (%)1

Person
months

3193

298

102521

2.9 (2.6-3.2)

498 (96.5)
2695 (90.6)

18 (3.5)
280 (9.4)

14840
87681

1.2 (0.7-1.9)
3.2 (2.8-3.6)

Ref
2.7 (1.7-4.4) ***

2822 (91.2)
341 (93.7)
7 (100.0)
3 (100.0)
14 (100.0)
6 (100.0)

275 (8.8)
23 (6.3)
0 (0.0)
0 (0.0)
0 (0.0)
0 (0.0)

93086
8691
220
51
385
88

3.0 (2.6-3.3)
2.6 (1.7-3.9)
0.0
0.0
0.0

1.1 (0.7-1.7)
Ref

181 (94.8)
1323 (93.2)
1639 (90.0)
50 (83.3)

10 (5.2)
97 (6.8)
181 (10.0)

4575
44805
51938

10 (16.7)

1203

2.2 (1.1-3.9)
2.2 (1.8-2.6)
3.5 (3.0-4.0)
8.3 (4.214.8)

Ref
1.0 (0.5-2.0)
1.6 (0.9-3.2)
3.8 (1.5-9.4) **

1972 (89.9)
49 (90.7)
1772 (92.7)

154 (10.1)
5 (9.3)
139 (7.3)

45826
1601
55094

3.4 (2.9-3.9)
3.1 (1.1-6.9)

Ref
0.9 (0.3-2.0)

2368 (89.9)
825 (96.2)

265 (10.1)
33 (3.8)

92749
9772

2.9 (2.5-3.2)
3.4 (2.4-4.7)

Ref
1.2 (0.8-1.7)

1672 (91.7)
1521 (91.2)

152 (8.3)
146 (8.8)

53593
48928

2.8 (2.4-3.3)
3.0 (2.5-3.5)

Ref
1.1 (0.8-1.3)

1394 (87.3)
1799 (94.9)

202 (12.7)
96 (5.1)

76575
25946

2.6 (2.3-3.0)
3.7 (3.0-4.5)

Ref
1.4 (1.1-1.8) **

991 (90.5)
114 (88.4)
2088 (92.1)

104 (9.4)
15 (11.6)
179 (7.9)

32884
4163
65474

3.2 (2.6-3.8)
3.6 (2.1-5.8)

Ref
1.2 (0.7-2.0)

Rate of
conversion
per 1000
person
months
(95%CI)

Incident Rate
Ratio per 1000
person months
(95%CI)

36
Substance Abuse6
No
793 (90.2)
86 (9.8)
28338
3.0 (2.4-3.7)
Ref
Yes
77 (92.8)
6 (7.2)
2931
2.0 (0.8-4.2)
0.7 (0.3-1.5)
Missing3
2323 (91.9)
206 (9.1)
71252
Number of Follow-up
screenings7
1-3
2735 (91.8)
245 (8.2)
75319
3.3 (2.9-6.7)
1.5 (1.1-2.2) *
4-6
385 (89.5)
45 (10.5)
21432
2.1 (1.6-2.8)
Ref
7-15
73 (90.1)
8 (9.9)
5770
1.4 (0.6-2.6)
0.7 (0.3-1.4)
Abbreviations: TST – Tuberculin Skin Test; QFT – QuantiFERON-Tuberculosis; PEH – Persons
Experiencing Homelessness; HIV – Human Immunodeficiency Virus.
1
Table displays the column numbers followed by row percentage in parenthesis.
2
Table does not include Transgender race due to a small sample size of less than 5.
3
Rate and rate ratio not calculated for missing data.
4
HIV was defined as any HIV screening test conducted and/or self-reported diagnosis.
5
Diabetes was defined as a self-reported diagnosis.
6
Any substance abuse was defined as self-reported excessive alcohol use or injection/non-injection drug
use.
7
Follow-up screenings after the entry screening.
*p≤.05. **p≤.01. ***p≤ .001
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Table 3. Rate of incident tuberculosis (TB) infection screening result reversion from positive to
negative among persons experiencing homelessness in Atlanta, Georgia, 2008-2018

Socio-demographic
Characteristics

All PEH N = 241
Gender2
Female
Male
Race3
Non-Hispanic
Black
Non-Hispanic
White
Asian
Age group
18-24
25-44
45-65
65+
HIV5
Negative
Positive
Missing4
Screening Type
TST
QFT
Missing4
Screening Location
Clinic
Field
Year of entry
screening
Pre – 2015
Post – 2015

No. reversion
observed
During
subsequent
TB screening
(%)1

Reverted to
negative
during
subsequent
screenings
(%)1

Person
months)

Rate of reversion
per 1000 person
months (95%CI)

153

88

6655

13.2 (10.7-16.2)

12 (52.2)
141 (64.7)

11 (47.8)
77 (35.3)

615
6040

17.9 (9.4-31.1)
12.7 (10.115.8)

Ref
7.1 (3.9-14.1)

78 (35.0)

6277

12.4 (9.9-15.4)

4.1 (2.1-9.1) *

8 (53.3)

264

30.0 (14.1-57.5)

Ref

1 (33.3)

2 (66.7)

114

17.5 (2.9-57.9)

5.8 (0.8-25.0)

0 (0.0)
41 (63.1)
102 (62.6)

1 (100.0)
24 (36.9)

1
1853

61 (37.4)

4736

1.0 (0.0-5.0)
12.9 (8.4-19.0)
12.9 (9.9-16.4)

10 (83.3))

2 (16.7)

65

30.8 (5.1-101.7)

Ref
13.0 (2.4-269.2)
12.8 (2.5-261.5)
*
30.8 (2.3-907.6)

94 (65.7)
4 (66.7)
55 (59.8)

49 (34.3)
2 (33.3)
37 (40.2)

3543
131
2981

13.8 (10.3-18.1)
15.3 (2.6-50.4)

Ref
11.0 (1.8-38.1)

101 (65.2)
47 (69.1)
5 (27.8)

54 (34.8)
21 (30.9)
13 (72.2)

5942
596
117

90.9 (68.9-117.7)
35.2 (22.4-52.9)

Ref
3.9 (2.3-6.3) ***

83 (66.9)
70 (59.8)

41 (33.1)
47 (40.2)

3702
2953

11.2 (8.0-14.9)
15.9 (11.8-21.0)

Ref
14.4 (9.4-21.9)

71 (67.0)
82 (60.7)

35 (33.0)

5506

53 (39.3)

1149

6.4 (4.5-8.7)
4.6 (3.5-6.0)

145 (65.0)
7 (46.7)

Incident Rate
Ratio per 100
person months
(95%CI)

Ref
7.3 (4.7-11.2)
***

38
Diabetes6
No
Yes
Missing3
Substance Abuse7
No
Yes
Missing3
Number of Followup screenings8
1-3
4-6
7-15

58 (63.7)
8 (53.3)
87 (64.4)

33 (36.3)
7 (46.7)
48 (35.6)

2521
297
3837

13.1 (9.2-18.2
23.6 (10.3-46.6)

Ref
18.0 (7.3-39.2)

38 (63.3)
2 (40.0)
113 (64.2)

22 (36.7)
3 (60.0)
63 (35.8)

1602
118
4935

13.7 (8.8-20.5)
25.4 (6.5-69.2

Ref
18.5 (4.4-56.2)

153 (64.8)
0 (0.0)
0 (0.0)

83 (35.2)
4 (100.0)
1 (100.0)

6463
127
65

12.8 (10.3-15.8)
31.5 (10.-7.6)
15.4 (0.8-75.9)

4.1 (1.6-13.1)
Ref
24.5 (7.6-61.1)

Abbreviations: TST – Tuberculin Skin Test; QFT – QuantiFERON-Tuberculosis; PEH – Persons
Experiencing Homelessness; HIV – Human Immunodeficiency Virus.
1
Table displays the column numbers followed by percentage in parenthesis.
2
Table does not include Transgender race due to a small sample size of less than 5.
3
No observations for sub-categories of Race (Hispanic and Other).
4
Rate and rate ratio not calculated for missing data.
5
HIV was defined as any HIV screening test conducted and/or self-reported diagnosis.
6
Diabetes was defined as a self-reported diagnosis.
7
Any substance abuse was defined as self-reported excessive alcohol use or injection/non-injection drug
use.
8
Follow-up screenings after the entry screening.
*p≤.05. **p≤.01. ***p≤ .001
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Table 4. Distribution of demographic characteristics and follow-up screening status among
persons experiencing homelessness in Atlanta, Georgia, 2008 - 2018
Socio-demographic
Characteristics

Total
Gender
Female
Male
Transgender
Race
Non-Hispanic Black
Non-Hispanic White
Asian
Hispanic
Other
Missing
Age group
0-24
25-44
45-65
65+
Screening Type
TST
QFT
Missing

PEH with
follow-up
screenings
N (%)1
N=3732

PEH without
follow-up
N (%)1

539 (14.4)
3193 (85.6)

3000 (23.6)
9676 (76.1)
36 (0.3)

3320 (89.0)
379 (10.1)
10 (0.3)
3 (0.1)
14 (0.4)
6 (0.1)

10730 (84.4)
1739 (13.7)
51 (0.4)
42 (0.3)
97 (0.8)
50 (0.4)

192 (5.1)
1485 (39.9)
1983 (53.1)
72 (1.9)

990 (7.8)
5532 (43.5)
5908 (46.5)
279 (2.2)

2788 (74.7)
926 (24.8)
18 (0.5)

6958 (54.7)
5638 (44.4)
113 (0.9)

N=12712

Abbreviations: TST – Tuberculin Skin Test; QFT – QuantiFERON-Tuberculosis; PEH – Persons
Experiencing Homelessness; HIV – Human Immunodeficiency Virus.
1
Table displays the column numbers followed by percentage in parenthesis.
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Figure 1. Study participant flowchart of total number of persons experiencing homelessness in
the main cohort in Atlanta, Georgia, 2008 - 2018

Total number of individuals
screened
N= 19221
Removed individuals with:
Missing screening result N=135
Indeterminate/Not read
screening result N= 2341
Age 0-17years = 301
Total number of individuals
in main cohort
N= 16444

Negative screening result

Positive Screening Result

N= 14841 (90.3%)

N = 1603 (9.7%)

Removed individuals with
no follow up screenings

Removed individuals with
no follow up screenings

N= 11350

N= 1362

N=3491

N=241

TST

QFT

TST

QFT

Missing screening type

N=2633

N= 855

N= 155

N= 68

N=18
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Figure 2. Rate of conversions from negative to positive TB screening during follow-up among persons
experiencing homelessness in Atlanta, Georgia, 2008-2018.

Rate of conversions from negative to positive TB screening during follow up
among persons experiencing homelessness in Atlanta, GA, 2008-2018
10

Rate (per 1,000 person months)

9
8
7

6
5
4

3
2
1

0
Overall

Male vs.
Female

Age: 25-44 vs. Age: 65+ vs. Test type: QFT Yr: '08-'11 vs. Diabetes: Yes F/up: 1 to 3 vs.
18-24 yrs
18-24 yrs
vs. TST
'16-'18
vs. No
4-6
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